🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jimmy S. Patel

Emory Healthcare

ORCID: 0000-0002-7322-7578

Also affiliated with Emory University, Universitat de València, Emory University Hospital, Cancer Institute (WIA), Piedmont Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of systemic therapy regimen on survival of PCNSL.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2070
Top 100%
0DataRank
Top 100%0 citations

Alfredo Voloschin, Jimmy S. Patel, Manali Rupji, Kimberly Hoang, Jeffrey J. Olson +5 more

Papers

Driven by 14 papers — median percentile 0. Top paper: “Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs”.

Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs

PLoS Biology(2021)10.1371/journal.pbio.3001355
N/A
0DataRank · unranked
21 citations

Calvin M. Johnson, Yong‐Mo Ahn, Kyle M. Kremiller, Matthew Sherwood, Jimmy S. Patel +10 more

Development of amidase-dependent pyrazinoic acid prodrugs with activity against pyrazinamide resistant Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.07.05.496887
N/A
0DataRank · unranked
1 citations

Ravindra D. Jadhav, Yan Pan, Kholiswa Tsotetsi, Xin Wang, Divya Awasthi +18 more

Impact of systemic therapy regimen on survival of PCNSL.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2070
Top 100%
0DataRank
Top 100%0 citations

Alfredo Voloschin, Jimmy S. Patel, Manali Rupji, Kimberly Hoang, Jeffrey J. Olson +5 more

Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008011
N/A
0DataRank · unranked
32 citations

Yena Woo, Amber Draper, Caroline S. Jansen, Jennifer W. Carlisle, Pasquale F. Innominato +10 more

Immune System Dose With Proton Versus Photon Radiotherapy for Treatment of Locally Advanced NSCLC

International Journal of Particle Therapy(2024)10.1016/j.ijpt.2024.100016
N/A
0DataRank · unranked
2 citations

Neal S. McCall, M.A. Thomas, Jun Zhou, Kristin Higgins, Jeffrey D. Bradley +5 more

Preclinical Evaluation of Azabenzimidazole‐Based PET Radioligands for γ‐8 Dependent Transmembrane AMPA Receptor Regulatory Protein Imaging

ChemBioChem(2024)10.1002/cbic.202300813
N/A
0DataRank · unranked
1 citations

Yinlong Li, Qingzhen Yu, Jimmy S. Patel, Xin Zhou, Kuo Zhang +13 more

Imaging poly(ADP-ribose) polymerase-1 (PARP1) in vivo with 18F-labeled brain penetrant positron emission tomography (PET) ligand

ChemRxiv(2024)10.26434/chemrxiv-2024-8pqmg-v2
N/A
0DataRank · unranked
2 citations

Jiahui Chen, Jimmy S. Patel, Wenqing Ran, Yinlong Li, Richard Van +19 more

Imaging poly(ADP-ribose) polymerase-1 (PARP1) in vivo with 18F-labeled brain penetrant positron emission tomography (PET) ligand

Acta Pharmaceutica Sinica B(2025)10.1016/j.apsb.2025.05.020
N/A
0DataRank · unranked
13 citations

Jiahui Chen, Jimmy S. Patel, Wenqing Ran, Yinlong Li, Richard Van +19 more

Development of a Novel 18F-Labeled Radioligand for Imaging Phosphodiesterase 7 with Positron Emission Tomography

Molecular Pharmaceutics(2025)10.1021/acs.molpharmaceut.4c01379
N/A
0DataRank · unranked
6 citations

Chunyu Zhao, Ahmad Chaudhary, Evan R. Jones, Richard Van, Zhendong Song +15 more

Development of a novel 18F-labeled reversible-binding radioligand for imaging monoacylglycerol lipase with positron emission tomography

Acta Pharmaceutica Sinica B(2025)10.1016/j.apsb.2025.05.041
N/A
0DataRank · unranked
3 citations

Chunyu Zhao, Ahmad Chaudhary, Tim Ware, Richard Van, Yinlong Li +16 more

Emerging Molecular PET Imaging for Cell Death in Neurodegenerative Diseases

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c01512
N/A
0DataRank · unranked
2 citations

Jing Yang, Jimmy S. Patel, Rui Lv, Zhijie Zhang, Xin Ji +4 more

Development of Novel 18 F-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00474
N/A
0DataRank · unranked
1 citations

Chunyu Zhao, Ahmad Chaudhary, Jiahui Chen, Yinlong Li, Xin Zhou +12 more

Preclinical Evaluation of [ 18 F]P4B-2412 as Phosphodiesterase 4B Radioligand for Positron Emission Tomography Imaging

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.16.633384
N/A
0DataRank · unranked
1 citations

Yinlong Li, Siyan Feng, Jiahui Chen, Xin Zhou, Zhixu Zhang +12 more

The Promise of Selective PARP1 Inhibitors in Cancer Therapy

ACS Medicinal Chemistry Letters(2025)10.1021/acsmedchemlett.5c00561
N/A
0DataRank · unranked
1 citations

Jimmy S. Patel, Taoqian Zhao, Steven H. Liang, Xin Zhou